Browse New Popular Keyword Cloud Advanced Search Submit a Link
All ArtsBusinessChildrenComputersGamesHealthHomeNewsRecreationReferenceRegionalScienceShoppingSocietySports

News on INS-1

corporate-ir.net
Visit Site

Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS).

Category
D-chiro-Inositol
Visits
432
Added
Nov 1, 2025
Rating
(144)
Rate This Site
More in D-chiro-Inositol Report
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.
Submit Your Site

Add your website to our directory for free.

Submit a Link
Get the best links delivered weekly — hand-picked from 1,200,810 resources